The scientific literature says little about KPVs safety profile, but there are concerns that it carries significant potential risks
Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA
When Results Plateau In community-reported reta+cagri protocols, plateaus are commonly reported at: Month 68 for users who hold retatrutide at 2 mg/week typically resolves by titrating retatrutide to 3 mg or holding while cagrilintide finishes ramping to 2.4 mg Month 12+ for users at the community ceiling (reta 4 mg + cagri 2.4 mg) no additional dose lever within the conservative community protocol
B12 shots are recommended for people who are deficient in B12
Kidney conditions may reduce the kidneys ability to filter and clear vitamin B12 and its binding proteins, also leading to higher measured levels
These convert phosphatidylinositol2-phosphate (PIP2) into phosphatidylinositol-3-phosphate (PIP3) and, by so doing, activates protein kinase B (PKB), the metabolic pathway for glycogen synthesis.1314 In addition to the conversion to phosphatidylinositol-3-phosphate, inositol also acts by activating pyruvate dehydrogenase kinase, isoenzyme 1